Former Arsenal Starlet Kyle Ebecilio Diagnosed with Guillain Barre Syndrome
August 3, 2016
Kyle Ebecilio, the former Arsenal youth prospect, has been diagnosed with Guillain Barre Syndrome – a rare disease which causes the body’s immune system attacks the nervous system.
Born in Rotterdam, Ebecilio was snapped up by Arsene Wenger in 2010 after fending off interest from a number of Premier League clubs.
The highly-rated midfielder was close to breaking into the first team after signing his first professional contract with the club but opted to return home to the Netherlands to begin senior football with FC Twente.
Last season Ebecilio joined Championship side Nottingham Forest on a season-long loan but, after a string of promising performances, was forced to return back to his parent club after a string of unfortunate injuries.
Looking to get regular first team action back at Twente, Ebecilio has suffered a huge set-back in pre-season training after a string of fitness tests unearthed the devastating diagnosis.
‘When Kyle at the beginning of the preparations went through the usual medical tests, he fell into negative out of tune,’ team doctor Bas Peijs FC Twente told Dutch press.
‘Not only with respect to his teammates, but also with respect to its results from previous years. Kyle also complained of a tingling sensation, had less power in his legs and pain in his back,’ he ad
After sending Ebecilio to a neurologist he was diagnosed with a mild case of Guillain Barre Syndrome – only 150 to 300 people in the Netherlands with this condition.
‘I remember when I the evening pulled a blanket over them in bed and did not feel like it feels normal,’ Ebecilio said.
‘I felt weak, had little balance. Right now I wanted to show in preparing what I have at home. In the summer, I even trained with a personal trainer, but I could – and still can – not give a hundred percent. Very frustrating.’
Read more: http://metro.co.uk/2016/07/26/former-arsenal-starlet-kyle-ebecilio-diagnosed-with-rare-disease-6031241/#ixzz4Fc9fuGwZ
Sign up for updates straight to your inbox.